The cell proliferation rate, which was measured by the percentage of Ki-67-positive tumor cells, was decreased in the group implanted with the miR-16 lentivirus and increased in the group treated with the KRAS plasmid (Fig. 5G and I). This evidence concerns the gene MKI67 and neoplasm.